ViaWealth’s GSK GSK Stock Holding History

ViaWealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$353K	Buy	6,738 +3	+0%	+$159	0.18%	131
2026 Q1	$372K	Sell	6,735 -1	-0%	-$54	0.21%	121
2025 Q4	$330K	Sell	6,736 -836	-11%	-$39K	0.19%	119
2025 Q3	$327K	Sell	7,572 -19	-0.3%	-$742	0.18%	130
2025 Q2	$291K	Sell	7,591 -2,035	-21%	-$77.8K	0.17%	133
2025 Q1	$373K	Sell	9,626 -4,864	-34%	-$178K	0.23%	117
2024 Q4	$490K	Sell	14,490 -4,357	-23%	-$157K	0.3%	97
2024 Q3	$770K	Sell	18,847 -2,394	-11%	-$97.9K	0.45%	72
2024 Q2	$818K	Sell	21,241 -994	-4%	-$41.8K	0.51%	64
2024 Q1	$953K	Sell	22,235 -645	-3%	-$26.6K	0.6%	51
2023 Q4	$848K	Sell	22,880 -8,100	-26%	-$291K	0.58%	51
2023 Q3	$1.12M	Buy	30,980 +1,665	+6%	+$59.1K	0.82%	30
2023 Q2	$1.04M	Buy	29,315 +1,725	+6%	+$61.9K	0.78%	32
2023 Q1	$982K	Buy	27,590 +9,475	+52%	+$331K	0.78%	33
2022 Q4	$626K	Buy	+18,115	New	+$603K	0.51%	69

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

ViaWealth's GSK Position: Q2 2026 in Review

ViaWealth increased its GSK (GSK) stake by 0.04% in Q2 2026, buying an estimated $159 and bringing the position to 6,738 shares worth $353K. The position accounts for 0.18% of the portfolio, ranked #131.

ViaWealth first reported a position in GSK in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.12M in Q3 2023. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

ViaWealth held 6,738 shares of GSK worth $353K as of Q2 2026.
ViaWealth bought 3 GSK shares in Q2 2026, an estimated $159.
GSK made up 0.18% of ViaWealth's portfolio in Q2 2026, its #131 holding.
ViaWealth first reported a position in GSK in Q4 2022 and has held it in 15 quarters since.
ViaWealth's GSK position peaked at $1.12M in Q3 2023.
1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on ViaWealth's 13F filing for Q2 2026, filed 11 Aug 2026.